Trial intelligence / Profile preview

Xpect: Oral Contraceptives in GnRH Antagonist Protocol

NCT00778999Phase 4Completed

Sponsor
Organon & Co.
Start
Oct 2006
Primary completion
Jul 2008
Modality
Small Molecules
01

Overview

Phase 4, randomised, open-label trial of ethinyl estradiol + desogestrel in infertility (2 arms), sponsored by Organon & Co. Primary endpoint: Total Number of Oocytes at 12 weeks. Started Oct 2006; status: completed.

02

Drugs

ethinyl estradiol + desogestrel
03

Conditions

infertility

Beyond the preview

Go deeper on NCT00778999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00778999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call